Taking these clinical aspects into consideration, one might designate individuals suffering from muscular diseases based on pathogenic variants affecting the DMD gene as dystrophinopathy patients. This evidence concerns the gene DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin.